Gerresheimer AGGRRMF 66 PEG Ratio is 28.26 as of Jul. 02, 2026, which is 471% above its 10-year median of 4.95. GuruFocus rates GRRMF with a GF Score™ of 66/100 and a GF Value™ of $108.04 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 207 Medical Devices & Instruments companies, Gerresheimer AG ranks worse than 97.1% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Gerresheimer AG's PEG Ratio or its related term are showing as below:
GRRMF'
s PEG Ratio Range Over the Past 10 Years
Min: 0.96 Med: 4.95 Max: 2634
Current: 27.45
During the past 13 years, Gerresheimer AG's highest PEG Ratio was 2634.00. The lowest was 0.96. And the median was 4.95.
GRRMF's PEG Ratio is ranked worse than 97.1% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs GRRMF: 27.45
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Gerresheimer AG (OTCPK:GRRMF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Gerresheimer AG PEG Ratio Related Terms
Gerresheimer AG PEG Ratio Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Gerresheimer AG (GRRMF) has a PEG Ratio of 28.26 as of Jul. 02, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Gerresheimer AG and its competitors. This is 471% above median its historical median of 4.95. Over the past decade, Gerresheimer AG's PEG Ratio has ranged from 0.96 to 2,634.00. According to the industry distribution chart, Gerresheimer AG ranks #201 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 97.1%.
Is Gerresheimer AG's PEG Ratio too high?
Gerresheimer AG's current PEG Ratio of 28.26 is 471% above median its 10-year median of 4.95. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 2,634.00. The Medical Devices & Instruments industry median PEG Ratio is 2.03. Gerresheimer AG's value of 28.26 is 1292.1% above this industry median. Based on the distribution chart, Gerresheimer AG ranks #201 out of 207 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Gerresheimer AG has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #201 out of 207 companies for PEG Ratio. This places Gerresheimer AG in the lower half of its industry. The industry median PEG Ratio is 2.03. Gerresheimer AG's value of 28.26 is 1292.1% above this benchmark. Historically, Gerresheimer AG's own PEG Ratio has ranged from 0.96 to 2,634.00 over the past decade. While the company's 10-year median is 4.95 vs. the industry median of 2.03, Gerresheimer AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.03, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current PEG Ratio of 28.26 is 1292.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current PEG Ratio is 28.26, which is 471% above median its own 10-year median of 4.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $108.04, compared to a current price of $30.73 — trading 71.6% below its estimated fair value. The current PEG Ratio is 28.26, which is 471% above median its 10-year median of 4.95 and 1292.1% above the Medical Devices & Instruments industry median of 2.03. Gerresheimer AG's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current PEG Ratio is 28.26 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (GRRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of $30.73 is trading 71.6% below its estimated GF Value™ of $108.04.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for GRRMF:
PEG Ratio: 28.26 (471% above median its 10-year median of 4.95)
GF Value™: $108.04 vs. price of $30.73 (71.6% below fair value)
Industry Position: 1292.1% above the Medical Devices & Instruments median (#201 of 207)
No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
66GF Score
Get the complete analysis for GRRMF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRRMF has been successfully added to your 
